Publicações

Health-Related Quality-Of-Life Results from the Phase 3 Optimismm Study: Pomalidomide, Bortezomib, and Low-Dose Dexamethasone Versus Bortezomib and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

AuthID
P-00S-XYY

Author(s)

Weisel, K

Dimopoulos, M

Moreau, P

Yagci, M

Larocca, A

Kanate, AS

Vural, F

Cascavilla, N

Basu, S

Johnson, P

[+6]·

Krauth, MT

Lucio, P

Ben Yehuda, D

Mendeleeva, L

Guo, SE

Yu, X

Grote, L

Biyukov, T

Dhanasiri, S

Richardson, P

View all authors

Tipo de Documento

Article in Press

Year published

2020

Publicado

in LEUKEMIA & LYMPHOMA, ISSN: 1042-8194

Indexing

Wos^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1080/10428194.2020.1747066

Wos: WOS:000558375200001

Source Identifiers

ISSN: 1042-8194

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Nome	Name Order	Nome	Name Order	Nome
1	Weisel, K;	2	Dimopoulos, M;	3	Moreau, P;
4	Yagci, M;	5	Larocca, A;	6	Kanate, AS;
7	Vural, F;	8	Cascavilla, N;	9	Basu, S;
10	Johnson, P;	11	Byeff, P;	12	Hus, M;
13	Rodriguez Otero, P;	14	Muelduer, E;	15	Anttila, P;
16	Hayden, PJ;	17	Krauth, MT;	18	Lucio, P;
19	Ben Yehuda, D;	20	Mendeleeva, L;	21	Guo, SE;
22	Yu, X;	23	Grote, L;	24	Biyukov, T;
25	Dhanasiri, S;	26	Richardson, P;

Health-Related Quality-Of-Life Results from the Phase 3 Optimismm Study: Pomalidomide, Bortezomib, and Low-Dose Dexamethasone Versus Bortezomib and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Health-Related Quality-Of-Life Results from the Phase 3 Optimismm Study: Pomalidomide, Bortezomib, and Low-Dose Dexamethasone Versus Bortezomib and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

Links Úteis

Ajuda